Generic drugmakers eye ₹5,000 crore semaglutide opportunity, but exports pathway fraught with hurdles
Semaglutide is the active ingredient in Novo Nordisk’s weightloss and diabetes drugs Wegovy and Ozempic
Semaglutide is the active ingredient in Novo Nordisk’s weightloss and diabetes drugs Wegovy and Ozempic